Sanofi SA
XETRA:SNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
XETRA:SNW
|
FR |
|
T
|
THEMAC Resources Group Ltd
XTSX:MAC
|
CA |
|
S
|
South32 Ltd
LSE:S32
|
AU |
|
J
|
Jeil M&S Co Ltd
KOSDAQ:412540
|
KR |
Wall Street
Price Targets
SNW Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for
SNW
is 97.77 EUR
with a low forecast of 57.56 EUR and a high forecast of 117.57 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SNW's stock price target?
Price Target
97.77
EUR
According to Wall Street analysts, the average 1-year price target for
SNW
is 97.77 EUR
with a low forecast of 57.56 EUR and a high forecast of 117.57 EUR.
What is Sanofi SA's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Sanofi SA's revenue is
2%.
The projected
CAGR
for the next 3 years is
5%.
What is Sanofi SA's Operating Income forecast?
Projected CAGR
12%
For the last 14 years the
compound annual growth rate for
Sanofi SA's operating income is
2%.
The projected
CAGR
for the next 3 years is
12%.
What is Sanofi SA's Net Income forecast?
Projected CAGR
16%
For the last 14 years the
compound annual growth rate for
Sanofi SA's net income is
2%.
The projected
CAGR
for the next 3 years is
16%.
